Fungal Transformation and Schistosomicidal Effects of Pimaradienoic Acid

Wiley - Tập 9 Số 8 - Trang 1465-1474 - 2012
Thiago S. Porto1, Ademar Alves da Silva Filho1, Lizandra Guidi Magalhães1, Raquel Alves dos Santos1, Niege Araçari Jacometti Cardoso Furtado2, Nilton Syogo Arakawa3, Suraia Said2, Dionéia Camilo Rodrigues de Oliveira2, Luiz Elídio Gregório2, Vanderlei Rodrigues4, Rodrigo Cássio Sola Veneziani1, Sérgio Ricardo Ambrósio1
1Núcleo de Pesquisa em Ciências Exatas e Tecnológicas, Universidade de Franca, Franca, SP, Brazil, (phone: +55-16-37118878)
2Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil
3Instituto de Pesquisa e Desenvolvimento da Universidade do Vale do Paraíba, São José dos Campos, SP, Brazil
4Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo – Ribeirão Preto/SP, Brazil

Tóm tắt

AbstractThe schistosomicidal effects of pimaradienoic acid (PA) and two derivatives, obtained by fungal transformation in the presence of Aspergillus ochraceus, were investigated. PA was the only compound with antischistosomal activity among the three diterpenes studied, with the ability to significantly reduce the viability of the parasites at concentrations ranging from 25 to 100 μM. PA also promoted morphological alterations of the tegument of Schistosoma mansoni, separated all the worm couples, and affected the production and development of eggs. Moreover, this compound was devoid of toxicity toward human fibroblasts. In a preliminary in vivo experiment, PA at a dose of 100 mg/kg significantly diminished the number of parasites in infected Balb/c mice. Taken together, these results show that PA may be potentially employed in the discovery of novel schistosomicidal agents, and that diterpenes are an important class of natural compounds for the investigation of agents capable of fighting the parasite responsible for human schistosomiasis.

Từ khóa


Tài liệu tham khảo

10.1371/journal.pmed.0030284

10.1016/j.cbpa.2007.05.031

10.1016/S1473-3099(06)70521-7

World Health Organization(WHO) ‘TDR Strategic Direction for Research: Schistosomiasis’ Geneva 2002.

10.1016/j.actatropica.2004.08.006

10.1016/S0001-706X(02)00045-1

10.1016/S0140-6736(03)14968-9

10.1021/jm0704090

10.1016/j.lfs.2006.05.015

10.1016/j.fitote.2009.06.003

10.1016/j.fitote.2010.05.018

10.1055/s-2006-957971

10.1515/znc-2005-9-1009

10.1016/j.bmc.2006.09.048

10.1002/ptr.2512

10.1248/bpb.29.1775

10.1111/j.1476-5381.2009.00609.x

10.1248/bpb.29.1050

10.1055/s-2003-42778

10.2174/0929867043365116

10.1016/j.phytochem.2009.09.005

10.1016/j.phytochem.2009.03.015

10.3390/molecules15096140

10.3390/molecules15128553

10.1016/S0040-4039(01)87979-X

10.1002/cbdv.200900292

10.1016/j.ijpara.2006.06.004

10.1371/journal.ppat.0030052

10.1016/S1471-4922(01)01893-1

10.1056/NEJMp0808041

10.3390/molecules16010762

10.1096/fj.06-7314com

10.1016/j.ijpara.2006.06.007

10.1021/np50047a021

10.1021/jo00408a041

10.1016/S0305-1978(03)00139-X

10.1016/0040-4039(76)90017-4

10.7164/antibiotics.46.34

10.1590/S0103-50532007000300020

10.1017/S0031182000086248

10.1016/0020-7519(89)90024-6

10.1016/j.exppara.2010.08.021

10.1007/s00436-009-1674-8

10.2307/3277120

10.1517/17460441.2.S1.S53

10.1038/nm1737

10.1017/S0031182000086248